Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Opioids
House Passes Sweeping Bi-Partisan Opioid Legislation CBO Outlines the Cost
Late last week, the US House of Representatives passed a series of bipartisans bills and combined them into one large bill to…
Health Canada Takes on Opioid Transparency – Notice of Intent to…
In the United States, the need for transparency when it comes to prescribing opioids has been a topic of discussion for months…
Purdue Pharma Battling More States Over Opioid Crisis
Oxycontin maker Purdue Pharma has been in the hot seat when it comes to the opioid crisis, as some feel that the company…
Twitter Holds Conversation on Opioids with Surgeon General, Members of…
Recently, Twitter D.C. and the Republican Main Street Partnership hosted a live conversation on Twitter on combating the opioid…
FDA Plans Opioid Summit June 27, 2018
Recently, United States Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., announced a one day Online Opioid…
Vermont’s Next Act: Wholesale Prescription Drug Importation Program
With Vermont Governor Phil Scott’s (R) signature on Senate Bill 175, Vermont now becomes the first-in-the-nation to enact a…
Opioid Class Action Suit Filed in Five States
On May 2, 2018, three law firms filed class action lawsuits against pharmaceutical manufacturers and distributors on behalf of…
Oklahoma Requires CME for Prescribers
Many states have taken the cue from the federal government and started their own investigation and research into opioids and the…
House Introduces Bill to Require CME for Controlled Substance Prescribing
House of Representatives member Representative Susan W. Brooks recently introduced the ADAPT Act of 2018. The ADAPT Act (Abuse…
Gottlieb Discusses Opioids and Lays Out Vision
On Wednesday, April 4, 2018, Food and Drug Administration (FDA) Commissioner Scott Gottlieb spoke at the National Rx Drug Abuse…